BQPrime
•Health
Health
75% Informative
GSK gained the medicine through last year’s $1.9 billion acquisition of US biotech Sierra Oncology .
The medicine, momelotinib, is likely to garner sales “comfortably” above $1 billion a year.
GSK has worked to rebuild its oncology pipeline after it sold off its cancer drugs portfolio to Novartis in 2015 .
VR Score
78
Informative language
82
Neutral language
82
Article tone
formal
Language
English
Language complexity
52
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links
Small business owner?
